Cardiovascular and Kidney Outcomes of Tirzepatide versus Semaglutide in Stage 2 Cardiovascular-Kidney-Metabolic Syndrome: A Propensity Score-matched Cohort Study

Authors
Category Systematic review
JournalClin. Med. Insights.Cardiol.
Year 2026
This article has no abstract
Epistemonikos ID: c66ef2c748d660f0d3208141eae349ca15a9af0e
First added on: Oct 24, 2026